Chinese Journal of Tissue Engineering Research ›› 2013, Vol. 17 ›› Issue (5): 920-930.doi: 10.3969/j.issn.2095-4344.2013.05.024

Previous Articles     Next Articles

Off-pump coronary artery bypass grafting treats high-risk coronary heart disease

Wang Shi-xiong1, 2, Li Ning-yin1, 2, Zhao Qi-ming1, Gao Bing-ren1   

  1. 1 Second Hospital of Lanzhou University, Lanzhou 73000, Gansu Province, China
    2 Second Clinical Medical College of Lanzhou University, Lanzhou 73000, Gansu Province, Chi
  • Received:2012-07-16 Revised:2012-09-05 Online:2013-01-29 Published:2013-01-29
  • Contact: Wang Shi-xiong★, Studying for master’s degree, Second Hospital of Lanzhou University, Lanzhou 73000, Gansu Province, China; Second Clinical Medical College of Lanzhou University, Lanzhou 73000, Gansu Province, China wangshi0815@163.com
  • About author:Wang Shi-xiong★, Studying for master’s degree, Second Hospital of Lanzhou University, Lanzhou 73000, Gansu Province, China; Second Clinical Medical College of Lanzhou University, Lanzhou 73000, Gansu Province, China wangshi0815@163.com

Abstract:

BACKGROUND: Off-pump coronary artery bypass grafting and on-pump coronary artery bypass grafting are the two surgical methods for the treatment of coronary atherosclerotic heart disease, but there is no systematic review on the comparison of these two methods in the treatment of high-risk coronary heart disease.
OBJECTIVE: To assess the effect and safety of off-pump versus on-pump coronary artery bypass grafting in perioperative period of high-risk coronary heart disease through Meta analysis.
METHODS: Relevant clinical trials published in English and Chinese from January 1993 to June 2012 were searched in PubMed database, EMbase database, China National Knowledge Infrastructure database, China Biomedicine Literature database, VIP database, Wanfang database and Cochrane Library (Issue 8, 2012). Manual searches of bibliographies were also performed. All the clinical trials were selected and analyzed according to the inclusion and exclusion criteria. Two reviewers independently selected eligible trials, performed quality assessment, and cross-checked each other. Finally, the abstracted relevant data was processed and analyzed with software RevMan 5.1.
RESULTS AND CONCLUSION: A total of 16 studies, including two randomized controlled trials and 14 retrospective studies were identified. A total of 6 441 high-risk patients, involving 2 948 in the off-pump coronary artery bypass grafting group and 3 493 in the on-pump coronary artery bypass grafting group were included. The results of Meta-analyses showed the differences of stroke, the intra-aortic balloon counterpulsation using, recurrent myocardial infarction, respiratory dysfunction and mortality incidence in the perioperative period, the ventilation time, the time in intensive care unit, hospitalization time, postoperative drainage and blood transfusion were significant between off-pump coronary artery bypass grafting and on-pump coronary artery bypass grafting patients. While there were no statistical differences in atrial fibrillation, acute renal injury, wound infection and reoperation rate. Compared with on-pump coronary artery bypass grafting in the perioperative period, using off-pump coronary artery bypass grafting for high-risk patients is safe and effective with the advantages of less trauma, lower operative mortality, rapider postoperative recovery and fewer complications, but because of the limited number of included studies and most is the non-randomized controlled trials, off-pump coronary artery bypass grafting cannot replace on-pump coronary artery bypass grafting. However, the results and long-term efficacy still need to be confirmed by higher-quality, more multi-center, large-sample and randomized double-blind controlled trials in the future.

Key words: organ transplantation, evidence-based medicine of organ transplantation, coronary atherosclerotic heart disease, coronary heart disease, off-pump cornary artery bypass, coronary artery bypass, off-pump, high risk, postoperative complications, atrial fibrillation, myocardial infarction, Meta-analysis, other grants-supported paper

CLC Number: